Attached files
| file | filename |
|---|---|
| 8-K - 8-K - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | d667958d8k.htm |
| EX-99.2 - EX-99.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | d667958dex992.htm |
| EX-99.1 - EX-99.1 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | d667958dex991.htm |
Exhibit 99.3
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Consolidated Statements of Cash Flow
(Unaudited)
| Years Ended December 31, | ||||||||||||
| (in thousands) | 2013 | 2012 | 2011 | |||||||||
| Cash flows from operating activities |
||||||||||||
| Net loss |
$ | (79,293 | ) | $ | (94,465 | ) | $ | (109,388 | ) | |||
| Adjustments to reconcile net loss to net cash used in operating activities |
||||||||||||
| Depreciation and amortization |
5,648 | 6,649 | 5,803 | |||||||||
| Amortization of debt discount and financing costs |
595 | — | — | |||||||||
| Stock-based compensation |
9,905 | 9,705 | 12,384 | |||||||||
| Other items |
(418 | ) | 287 | 226 | ||||||||
| Changes in assets and liabilities |
||||||||||||
| Accounts receivable |
76 | 1,735 | (4,216 | ) | ||||||||
| Inventory |
(60 | ) | 4,761 | (11,409 | ) | |||||||
| Prepaid expenses and other assets |
906 | 1,058 | 1,874 | |||||||||
| Accounts payable |
(1,271 | ) | (1,754 | ) | (4,773 | ) | ||||||
| Accrued expenses and other current liabilities |
1,593 | (2,054 | ) | 3,044 | ||||||||
| Deferred service revenue |
386 | (1,674 | ) | 2,631 | ||||||||
| Deferred development revenue |
33,304 | — | — | |||||||||
| Lease incentives and other long-term liabilities |
(1,204 | ) | (1,070 | ) | 850 | |||||||
|
|
|
|
|
|
|
|||||||
| Net cash used in operating activities |
(29,833 | ) | (76,822 | ) | (102,974 | ) | ||||||
|
|
|
|
|
|
|
|||||||
| Cash flows from investing activities |
||||||||||||
| Purchase of property and equipment |
(909 | ) | (1,703 | ) | (9,284 | ) | ||||||
| Purchase of investments |
(201,547 | ) | (87,889 | ) | (264,071 | ) | ||||||
| Sales of investments |
100 | 7,896 | 36,520 | |||||||||
| Maturities of investments |
169,239 | 143,488 | 243,281 | |||||||||
|
|
|
|
|
|
|
|||||||
| Net cash provided by (used in) investing activities |
(33,117 | ) | 61,792 | 6,446 | ||||||||
|
|
|
|
|
|
|
|||||||
| Cash flows from financing activities |
||||||||||||
| Proceeds from issuance of common stock from equity plans |
3,079 | 2,705 | 7,743 | |||||||||
| Proceeds from issuance of common stock from equity offering, net of issuance costs |
19,927 | — | — | |||||||||
| Proceeds from issuance of debt facility, net of issuance costs |
19,766 | — | — | |||||||||
|
|
|
|
|
|
|
|||||||
| Net cash provided by financing activities |
42,772 | 2,705 | 7,743 | |||||||||
|
|
|
|
|
|
|
|||||||
| Net decrease in cash and cash equivalents |
(20,178 | ) | (12,325 | ) | (88,785 | ) | ||||||
| Cash and cash equivalents at beginning of period |
46,540 | 58,865 | 147,650 | |||||||||
|
|
|
|
|
|
|
|||||||
| Cash and cash equivalents at end of period |
$ | 26,362 | $ | 46,540 | $ | 58,865 | ||||||
|
|
|
|
|
|
|
|||||||
| Supplemental disclosure of cash flow information |
||||||||||||
| Interest paid |
1,165 | — | — | |||||||||
| Supplemental disclosure of non-cash investing and financing activities |
||||||||||||
| Inventory transferred to property and equipment for internal use |
558 | 1,164 | 2,756 | |||||||||